Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Fertility - Video

Merck KGaA, Darmstadt, Germany Announces Exclusive License Agreement with Auxogyn for Eeva Test

This agreement supports EMD Serono’s vision, as a world leader in fertility treatment, to develop and provide innovative products, devices and support services to help infertile couples at every stage of the fertility treatment cycle.
The Eeva® Test is designed to provide objective embryo viability data to in vitro fertilization (IVF) clinicians and to help improve patient outcomes.

Fertility – Investing in Innovative Healthcare Solutions

EMD Serono is the only drug-maker to offer a full portfolio of fertility drugs for every stage of the reproductive cycle and recombinant versions of the three hormones needed to treat infertility. The Eeva® Test is a non-invasive diagnostic test used adjunctively to traditional morphology.
Under the terms of the in April announced agreement, EMD Serono will obtain full commercialization rights to market the Eeva Test in Europe and Canada, with the option to extend to selected countries. 
The agreement is the latest development in the ongoing collaboration between EMD Serono and Auxogyn, which began in 2010 when Merck KGaA, Darmstadt, Germany invested in Auxogyn through its corporate venture capital fund, MS Ventures.


Helps couples who want to conceive: The Eeva® test increases the success rate of in vitro fertilization
Helps couples who want to conceive: The Eeva® test can help to increase the success rate of in vitro fertilization


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.


Gangolf Schrimpf
Tel: +49 6151 72-9591
Fax: +49 6151 72-919591
Merck KGaA, Darmstadt, Germany on Facebook